EnglishעבריתEspañol
🌍 Worldwide🎗️ Cancer & Oncology📡 openFDA🕒 Updated November 2, 2026

Newly Approved Cancer Drugs (FDA) – 2026

As of November 2, 2026, “ETCAMAH” leads Newly Approved Cancer Drugs (FDA) with 2026-09-04. “ZENBEXUS” is second and “JIDEYTRO” third.

🚫 No paid placement📡 Source: openFDA🕒 Updated November 2, 2026 ⓘ How we measure

Full ranking

1
🎗️
ETCAMAH ↗ •🏆 Leader
camizestrant · ASTRAZENECA
2026-09-04Approval date
2
🎗️
ZENBEXUS ↗ •
iberdomide hydrochloride · BRISTOL MYERS SQUIBB
2026-08-13Approval date
3
🎗️
JIDEYTRO ↗ •
zidesamtinib · NUVALENT
2026-07-22Approval date
4
🎗️
ZYOGREEN ↗ •
indocyanine green · PROVEPHARM SAS
2026-07-10Approval date
5
🎗️
NAVITRUX ↗ •
fosaprepitant dimeglumine · AVYXA HOLDINGS
2026-06-24Approval date
6
🎗️
VEPPANU ↗ •
vepdegestrant · RIGEL PHARMS
2026-05-01Approval date
7
🎗️
LIFYORLI (COPACKAGED) ↗ •
relacorilant · CORCEPT THERAP
2026-03-25Approval date
8
🎗️
PYLARIFY TRUVU ↗ •
piflufolastat f-18 · APHELION
2026-03-06Approval date
9
🎗️
VYKOURA ↗ •
leucovorin calcium · AVYXA HOLDINGS
2026-02-03Approval date
10
🎗️
KOMZIFTI ↗ •
ziftomenib · KURA
2025-11-13Approval date

How this ranking works

New drug applications approved by the US FDA in the last 12 months whose labeled use is cancer, newest first (openFDA). For information only, not medical advice.

Methodology →

SourceopenFDA
SignalApproval date
Last updatedNov 2, 2026, 4:27 PM UTC
Top 10Original applications approved in the last 12 months

Frequently asked questions

What is #1 in Newly Approved Cancer Drugs (FDA)?

As of November 2, 2026, #1 is “ETCAMAH”.

How is this ranking measured?

New drug applications approved by the US FDA in the last 12 months whose labeled use is cancer, newest first (openFDA). For information only, not medical advice.

How often is this chart updated?

Data is re-collected automatically and every page shows its last update date.

Can a brand pay to appear in this ranking?

No. There are no paid placements and no commercial influence on rank.

More rankings for you